In humans, polyglutamine (polyQ) expansion in ATXN7 results in SCA7, a dominant neurodegenerative disorder distinguished from other ataxias by retinopathy (David et al. 1997; Enevoldson et al. 1994). This evidence concerns the gene ATXN7 and retinal disorder.